Conmed CNMD
NYSE CNMD
$46.99 +0.40 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Conmed (CNMD) Revenue Growth (3y) (2013 - 2026)

Analysis

Conmed (CNMD) Revenue Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 18.10%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 8.20%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 9.66%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 10.83%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 4.73%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 14.51%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 8.05%
10 Conmed 1.48 Bn 1.44 Bn 197.46 Mn 2.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.64%
Mar 31, 2026 2.38%
Dec 31, 2025 14.16%
Sep 30, 2025 7.10%
Jun 30, 2025 7.29%
Mar 31, 2025 9.85%
Dec 31, 2024 8.09%
Sep 30, 2024 8.37%
Jun 30, 2024 9.18%
Mar 31, 2024 10.30%
Dec 31, 2023 8.96%
Sep 30, 2023 8.59%
Jun 30, 2023 26.27%
Mar 31, 2023 11.35%
Dec 31, 2022 -1.79%
Sep 30, 2022 5.60%
Jun 30, 2022 5.17%
Mar 31, 2022 3.53%
Dec 31, 2021 4.16%
Sep 30, 2021 7.14%